Power Law company profile

Celator Pharmaceuticals

Biotech & Life Sciences · Dublin, Ireland · Founded 1999 · IPO 2013 Unicorn

Operator of a pharmaceutical company intended to improve clinical outcomes

Valuation

$1.50B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

8 investors on Celator Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Business Development Bank of Canada

Series B+ 7 investors entered at this stage

Ventures West

Valence Life Sciences

Domain Associates

Thomas McNerney & Partners

BC Cancer Agency

ROTH Capital Partners

TL Ventures

Celator Pharmaceuticals mafia

Startups founded by Celator Pharmaceuticals alumni

Former Celator Pharmaceuticals employees who went on to start their own companies. Sorted by Dealroom signal score.

Upward HealthEst. 2017

EHEric HeilUnited States

Signal score90

NeurogastrxEst. 2012

Cyril De ColleUnited States

Signal score61

LucasPye BIOEst. 2018

TLTia L.United States

Signal score39

Larrk BioEst. 2018

FGFrederic GodderisUnited States

Signal score35

Book a demo to explore the full alumni network →

Global footprint

Where Celator Pharmaceuticals has talent and traffic

Workforce by country

🇮🇪 Ireland · Dublin HQ

Book a demo for the full country breakdown

Patent intelligence

$32M patent portfolio · 14 active families

Estimated portfolio value

$32M

2.2% of market cap · 5.1× smaller than top peer Amicus Therapeutics ($164M)

14 active patent families

Where Celator Pharmaceuticals innovates PharmacologyDrugTherapeutic effectDelivery vehicleCamptothecin

Where Celator Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Celator Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Celator Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Celator Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Celator Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles